Joint work with Nanomedicine institutional stakeholders
The non-profit organisation CLINAM Foundation is the leading partner organising this major conference on Nanomedicine in Europe and works in collaboration with the European Technology Platform on Nanomedicine (ETPN) and the European Medicines Agency (EMA). Further partners are the European Society for Nanomedicine (ESNAM) and the European Science Foundation (ESF).
ETPN’s focus on generating European projects and translational issues
The ETP Nanomedicine contributes to CLINAM 2011 by organising 3 of 23 sessions held during the conference. The emphasis is on European Policy and funding, industrial challenges and projects’ proposals for joint collaborative research:
– Strategic Vision, Future Joint Research and Translation of Results, Needs for Policy Initiatives for the Benefit of the Patient (24th May 2011 – 11:15)
– Industrial Perspectives of Nanomedicine 2011 – 2020: Round table with six representatives from academia and industry (24th May 2011 – 12:00)
– ETPN Flash Proposals Session: Presentation of ideas for collaborative research projects (25th May 2011 – 10:45)
About the European Technology Platform on Nanomedicine – ETPN
The ETPN was established in 2005 as a joint venture of the European Commission, large industrial companies, SMEs and academic research institutions to investigate and advance joint activities in the area of medical nanotechnology. The ETPN contributed to the set up of numerous European-funded projects. The aim is to reach an efficient translation of R&D results into innovative products and to set the dialog with European legislation and regulations authorities. The ETPN supports its members with the coordination of their joint research efforts and the improvement of communication between the European Commission and the European Member States.
For more information, the full programme and to register for CLINAM 2011 check:
Dr. Sebastian Lange, Nicolas Gouze
ETP Nanomedicine Secretariat
Tel.: +49 30 310078-155